Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.
Regeneron and SocietyforScience
Shared 1 day ago
94 views
Regeneron and SocietyforScience
Shared 1 week ago
222 views
Regeneron and SocietyforScience
Shared 2 weeks ago
2.3K views
Regeneron and SocietyforScience
Shared 4 weeks ago
777 views
Shared 1 month ago
473K views
Regeneron and SocietyforScience
Shared 1 month ago
1.8K views
Shared 1 month ago
143 views
Shared 1 month ago
57 views
Shared 2 months ago
107 views
Shared 2 months ago
305 views
Shared 3 months ago
207 views
Shared 4 months ago
329 views
Shared 5 months ago
129 views
Shared 5 months ago
41K views
Shared 5 months ago
175 views
Shared 5 months ago
103K views
Shared 8 months ago
734 views
Shared 8 months ago
145 views
Shared 10 months ago
437 views
Shared 10 months ago
18K views
Shared 10 months ago
23K views
Shared 10 months ago
301 views
Shared 11 months ago
578 views
Shared 1 year ago
403 views
Shared 1 year ago
299 views
Shared 1 year ago
338 views
Shared 1 year ago
396 views
Shared 1 year ago
420 views
Shared 1 year ago
3.3M views
Shared 1 year ago
231 views
Shared 1 year ago
1.6K views
Shared 2 years ago
419K views
Shared 3 years ago
3.1K views
Shared 3 years ago
28K views
Shared 3 years ago
11K views
Shared 3 years ago
28K views